Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
40
NGVT Quote, Financials, Valuation and Earnings
Last price:
$46.30
Seasonality move
:
-5%
Day range:
$45.24 - $46.62
52-week range:
$28.49 - $51.67
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.25x
P/B ratio:
7.20x
Volume:
229.5K
Avg. volume:
209K
1-year change:
-0.39%
Market cap:
$1.7B
Revenue:
$1.4B
EPS (TTM):
-$9.74
Earnings Data
Next earnings date for NGVT
Jul 31
2025
Most recent earnings per share
$0.56
Missed by $0.18
(May 6/2025)
Consensus Estimate
$0.74
(May 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
NGVT Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $372M | -- | -- | $1.31 | -- |
| 07/31/2025 | Q2 | $378.7M | -- | -- | $1.16 | -- |
| 05/06/2025 | Q1 | $285.5M | $284M | $0.56 | $0.74 | -$0.18 |
| 02/18/2025 | Q4 | $297.4M | $298.8M | $0.46 | $0.31 | $0.15 |
| 10/29/2024 | Q3 | $377M | $376.9M | -$2.95 | $0.88 | -$3.83 |
| 07/31/2024 | Q2 | $401.7M | $390.6M | -$7.81 | $1.04 | -$8.85 |
| 05/01/2024 | Q1 | $319.2M | $340.1M | -$1.54 | $0.25 | -$1.79 |
| 02/21/2024 | Q4 | $332.6M | $371.7M | -$3.23 | -$0.19 | -$3.04 |
| 11/01/2023 | Q3 | -- | -- | $0.69 | $1.23 | -$0.54 |
| 08/02/2023 | Q2 | -- | -- | $0.97 | $1.38 | -$0.41 |
| 05/03/2023 | Q1 | -- | -- | $1.35 | $1.11 | $0.24 |
| 02/27/2023 | Q4 | -- | -- | $0.41 | $0.87 | -$0.46 |
| 11/02/2022 | Q3 | -- | -- | $1.98 | $1.69 | $0.29 |
| 08/02/2022 | Q2 | -- | -- | $1.54 | $1.62 | -$0.08 |
| 05/04/2022 | Q1 | -- | -- | $1.55 | $1.04 | $0.51 |
| 02/23/2022 | Q4 | -- | -- | $0.74 | $0.78 | -$0.04 |
| 10/27/2021 | Q3 | -- | -- | -$0.11 | $1.54 | -$1.65 |
| 07/28/2021 | Q2 | -- | -- | $1.10 | $1.32 | -$0.22 |
| 04/28/2021 | Q1 | -- | -- | $1.20 | $1.03 | $0.17 |
| 02/10/2021 | Q4 | -- | -- | $1.23 | $0.77 | $0.46 |
| 10/28/2020 | Q3 | -- | -- | $1.69 | $1.01 | $0.68 |
| 07/29/2020 | Q2 | -- | -- | $0.49 | $0.60 | -$0.11 |
| 04/29/2020 | Q1 | -- | -- | $1.08 | $0.82 | $0.26 |
| 02/19/2020 | Q4 | -- | -- | $1.05 | $1.07 | -$0.02 |
| 10/23/2019 | Q3 | -- | -- | $1.41 | $1.40 | $0.01 |
| 07/24/2019 | Q2 | -- | -- | $1.36 | $1.33 | $0.03 |
| 05/01/2019 | Q1 | -- | -- | $0.99 | $0.98 | $0.01 |
| 02/13/2019 | Q4 | -- | -- | $1.07 | $0.77 | $0.30 |
| 10/24/2018 | Q3 | -- | -- | $1.16 | $1.04 | $0.12 |
| 07/25/2018 | Q2 | -- | -- | $1.12 | $1.00 | $0.12 |
| 05/02/2018 | Q1 | -- | -- | $0.79 | $0.63 | $0.16 |
| 02/20/2018 | Q4 | -- | -- | $0.45 | $0.36 | $0.09 |
| 11/01/2017 | Q3 | -- | -- | $0.86 | $0.76 | $0.10 |
| 08/02/2017 | Q2 | -- | -- | $0.78 | $0.70 | $0.08 |
| 05/04/2017 | Q1 | -- | -- | $0.49 | $0.47 | $0.02 |
| 02/23/2017 | Q4 | -- | -- | $0.34 | $0.30 | $0.04 |
Ingevity Earnings Questions
-
How Much did Ingevity Generate in Revenue Last Quarter?
Ingevity reported $284M worth of top line sales in its most recent quarter.
-
Did Ingevity Beat Earnings Last Quarter?
Ingevity announced earnings per share of $0.56 which represents a miss of analyst forecast a $0.74 per share.
-
Is Ingevity Profitable?
Ingevity reported $113.4M that represents $3.09 per share over the last quarter.
-
What is the Analyst Consensus for Ingevity EPS Next Year?
Ingevity's earnings are forecast to decrease from -$11.85 per share to $2.93 per share next year representing a decrease of -35.22%.
-
When is Ingevity's Earnings Date?
Ingevity's next earnings date is July 31, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
